Association of Campylobacter jejuni infection and Guillain-Barré syndrome: A cohort study in the northwest of Iran

Turkish Journal of Pediatrics

Volumn 50, Issue 5, 2008, Pages 443-448

  Barzegar, Mohammad ^a   Alizadeh, Asghar ^a   Toopchizadeh, Vahideh ^a   Dastgiri, Saeed ^a   Majidi, Jafar ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Campylobacter jejuni; Clinical; Electrophysiological; Guillain Barr syndrome

Indexed keywords

IMMUNOGLOBULIN; ANTIIDIOTYPIC ANTIBODY; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGE; ARTICLE; CAMPYLOBACTER JEJUNI; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; IRAN; MALE; NERVE FIBER DEGENERATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEASONAL VARIATION; CAMPYLOBACTERIOSIS; COMPARATIVE STUDY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGY; RISK FACTOR;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD, PRESCHOOL; ELECTROPHYSIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; IRAN; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 58149387228     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(Suppl): S21-S24.
2. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. Clin Infect Dis 1997; 176(Suppl): S92-S98.
3. Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP. A prospective study of acute idiopathic neuropathy II. Antecedent events. J Neurol Neurosurg Psychiatry 1988; 51: 613-618.
4. Blaser MJ, Reller LB. Campylobacter enteritis. N Engl J Med 1981; 305: 1444-1452.
5. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J 1984; 288: 1867-1870.
6. Rees JH, Hughes RA. Campylobacter jejuni and Guillain-Barré syndrome. Ann Neurol 1994; 35: 248-249.
7. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with Guillain-Barré syndrome. Ann Intern Med 1993; 118: 947-953.
8. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998; 51: 1110-1115.
9. Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. J Infect Dis 1997; 176(Suppl): S150-S153.
10. Guarino M, Casmiro M, D'Alecsandro R. Campylobacter jejuni infection and Guillain-Barré syndrome: a case control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology. Neuroepidemiology 1998; 17: 296-302.
11. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118: 597-605.
12. Blaser MJ, Duncan DJ. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun 1984; 44: 292-298.
13. Herbrink P, van den Munckhof HA, Bumkens M, Lindeman J, Van Dijk WC. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988; 7: 388-393.
14. Mishu B, Blaser MJ. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis 1993; 17: 104-108.
15. Kaldor J, Pritchard H, Serpell A, Metcalf W. Serum antibodies in Campylobacter enteritis. J Clin Microbiol 1983; 18: 1-4.
16. Hughes RA, Newson-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978; 2: 750-3.
17. Hadden RD, Cornblath DR, Highes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical association and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998; 44: 780-788.
18. Rhodes KM, Tattersfiled AE. Guillain-Barré syndrome associated with Campylobacter infection. Br Med J 1982; 285: 173-174.
19. Speed B, Kaldor J, Cavanagh P. Guillain-Barré syndrome associated with Campylobacter jejuni enteritis. J Infect Dis 1984; 8: 85-86.
20. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333: 1374-1379.
21. Saida T, Kuroki S. Hao Q, Nishimura M, Nukina M, Obayashi H. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome. J Infect Dis 1997; 176(Suppl): S129-S134.
22. Skirrow MB. A demographic survey of Campylobacter, Salmonella, and Shigella infections in England. A Public Health Laboratory Service Survey. Epidemiol Infect 1987; 99: 647-657.
23. Koga M, Ang CW, Yuki N, et al. Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and the Netherlands. J Neurol Neurosurg Psychiatry 2001; 70: 693-695.
24. Nachamkin I, Allos BM, Ho T. Campylobacter species and Guillain Barré syndrome. Clin Microbiol Rev 1998; 11: 555-567.
25. Cheng Q, Wang DS, Jiang GX, et al. Distinct pattern of age-specific incidence of Guillain-Barré syndrome in Harbin, China. J Neurol 2002; 249: 25-32.
26. Hadden RD, Karch H, Hartung HP, et al. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 2001; 56: 758-765.
27. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995; 118: 577-595.
28. Olive JM, Castil OC, Castro RG, Qaudros CA. Epidemiologic study of Guillain-Barré syndrome in children less than 15 years of ages in Latin America. J Infec Dis 1997; 175(Suppl): 160-164.
29. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990; 40: 1900-1902.
30. Barzegar M, Jalali Z, Topchizadeh V. Epidemiological, clinical and electrodiagnostic findings in childhood Guillain-Barré syndrome. Med J Islam Rep Iran 2003; 17: 123-127.
31. Mckhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333-342.